Generate Biosciences is a series b startup. 1 investor tracked. Status: possibledead.
Based in the United States, Generate Biosciences is a startup. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Generate Biomedicines is a clinical-stage generative biology company that uses machine learning and biological engineering to create novel protein therapeutics, pioneering a shift from drug discovery to drug generation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.